IGeneX's Management Buyout

IGeneX raised a round of funding on September 17, 2015. Investors include Management Buyout (MBO).

IGeneX is a CLIA certified reference laboratory providing testing services for Lyme disease and other tick-borne illnesses. The Company provides innovative, state-of-the-art clinical testing, includi…

Articles about IGeneX's Management Buyout: